Turn Therapeutics (Nasdaq: TTRX)

Inflammatory and Infectious Disease Research & Development

[Turn Therapeutics (Nasdaq: TTRX) @turnttrx]

https://t.co/39YY0btt52

[BioTech Health X @BioTechHealthX]

$TTRX Turn Therapeutics earns national recognition as one of the “Five Novel Mechanisms Reshaping Atopic Dermatitis Treatment.” Learn how the GX-03 IL-36–targeting technology could disrupt the $20B eczema market ahead of 2026 topline data. https://t.co/ZW5MYE7ZLw

[Turn Therapeutics (Nasdaq: TTRX) @turnttrx]

Our phase 2 drug candidate was named as one of five novel mechanisms reshaping the eczema treatment landscape. #eczema #dermatology $TTRX

https://t.co/iplUyN4RaT

[Turn Therapeutics (Nasdaq: TTRX) @turnttrx]

Honored to have been invited to this DC health policy summit. I built #TTRX on a simple belief: treat root causes…don’t manage crises. To be in a room where that philosophy is now part of the national conversation…that’s a full-circle moment.

-Brad

[Turn Therapeutics (Nasdaq: TTRX) @turnttrx]

How do we rebuild trust in public health? Dr. Robert Redfield @redfield_dr discusses with our CEO Bradley Burnam the lessons he learned as CDC Director during the #COVID pandemic.

Watch the full podcast episode on YouTube: https://t.co/Wz1TeeA0nj

[Turn Therapeutics (Nasdaq: TTRX) @turnttrx]

Our eczema technology was named one of five novel mechanisms reshaping the treatment landscape alongside giants like Amgen and Sanofi.

https://t.co/OAVPoDRqzX

[Turn Therapeutics (Nasdaq: TTRX) @turnttrx]

Our CEO sits down with former CDC Director Dr. Robert Redfield to discuss rebuilding public trust in science, a wound we must heal before the next crisis.

Episode drops Tuesday. Follow for the release!

@tonylyonspub @DrBobRedfield51 @skyhorsepub

#BreakingBradPodcast $ttrx

[Turn Therapeutics (Nasdaq: TTRX) @turnttrx]

We are enrolling the first subjects in our human clinical trial for the treatment and prevention of #COVID19.

Read the full press release: https://t.co/bT4t6iUQ5Y

#health #medicine #therapeutics #covid #clinicaltrials #research #biotech

[Turn Therapeutics (Nasdaq: TTRX) @turnttrx]

Turn Therapeutics Receives Authorization to Commence Human Trial for COVID-19 Therapeutic Candidate

#COVID19 #healthcare #Biotechnology
https://t.co/c3GTy0EovO

[Turn Therapeutics (Nasdaq: TTRX) @turnttrx]

#covid19 #handsanitizer #WashYourHands #InThisTogether

[Turn Therapeutics (Nasdaq: TTRX) @turnttrx]

Our CEO Bradley Burnam with some new insights on a product that is quickly becoming a necessary part of life; hand sanitizer.

https://t.co/RbZH0nHaug

[Turn Therapeutics (Nasdaq: TTRX) @turnttrx]

Our CEO, Bradley Burnam, was recently interviewed by @Entrepreneur regarding his pursuit for a cure that led to the creation of our platform technology and resulting products. Read the full interview: https://t.co/3AEaJTrDxA

#entrepreneur #pharmaceutical

[Turn Therapeutics (Nasdaq: TTRX) @turnttrx]

Watch our core technology in action 👇👇👇
#PermaFusion

https://t.co/7asQoxUBZ5

[Turn Therapeutics (Nasdaq: TTRX) @turnttrx]

#Doctors less satisfied, more burned out with #electronic records | Reuters https://t.co/JpHv40CCwq #mednews #health #healthtalk #er #med

[Turn Therapeutics (Nasdaq: TTRX) @turnttrx]

#Zika #vaccine 'works very well' in mice https://t.co/R4p07gK6b6 #research #medicine #health #healthcare #mednews

[Turn Therapeutics (Nasdaq: TTRX) @turnttrx]

Human #brain houses diverse populations of #neurons, new #research shows https://t.co/dO6gcRZebV #healthtalk #mednews #science #study #med

[Turn Therapeutics (Nasdaq: TTRX) @turnttrx]

Why Do We Inherit #Mitochondrial #DNA Only From Our Mothers? https://t.co/qLAx9UIOUT #medicine #health #science #med

[Turn Therapeutics (Nasdaq: TTRX) @turnttrx]

Is There A #Disease That Makes Us Love Cats? - Crazy #Cat Ladies Are Real, And This Is Why https://t.co/XrjzluwmWj

[Turn Therapeutics (Nasdaq: TTRX) @turnttrx]

Why It's So Hard to Innovate at Big #Medical Device Companies? https://t.co/4P0PExPsiD #business #innovation #health

[Turn Therapeutics (Nasdaq: TTRX) @turnttrx]

Hospitals need to spend big on #analytics, #telemedicine, #KPMG says https://t.co/FivDnQvqOV #healthcare #it #tech